Fasting apolipoprotein B48 is associated with large artery atherosclerotic stroke: a case-control study
Author:
Funder
Science & Technology Department of Sichuan Province, China
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-40385-0.pdf
Reference29 articles.
1. Kolovou, G. D. et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 9, 258–270 (2011).
2. Patel, A. et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110, 2678–2686, https://doi.org/10.1161/01.CIR.0000145615.33955.83 (2004).
3. Berger, J. S. et al. Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women. Stroke 43, 958–966, https://doi.org/10.1161/STROKEAHA.111.641324 (2012).
4. Shahar, E. et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 34, 623–631, https://doi.org/10.1161/01.STR.0000057812.51734.FF (2003).
5. Bowman, T. S. et al. Cholesterol and the risk of ischemic stroke. Stroke 34, 2930–2934, https://doi.org/10.1161/01.STR.0000102171.91292.DC (2003).
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NMR derived changes of lipoprotein particle concentrations related to impaired fasting glucose, impaired glucose tolerance, or manifest type 2 diabetes mellitus;Lipids in Health and Disease;2023-03-24
2. The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study);Frontiers in Cardiovascular Medicine;2023-01-25
3. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023
4. Could the chylomicron marker apoB48 be of value in the diagnosis of chylous effusions?;Clinica Chimica Acta;2023-01
5. Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment;Clinical Chemistry and Laboratory Medicine (CCLM);2022-06-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3